RVRC vs RVPH: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

RVPH has stronger fundamentals based on our AI analysis.

RVRC
Revium Rx.
STRONG SELL
88%
Confidence
VS
RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.
STRONG SELL
90%
Confidence

RVRC vs RVPH Fundamental Comparison

Metric RVRC RVPH
Revenue N/A $122,867.0
Net Income $-13.4M $-19.9M
Net Margin N/A -16,167.8%
ROE -195.5% -229.7%
ROA -162.1% -124.8%
Current Ratio 2.26x 2.08x
Debt/Equity 0.00x 0.00x
EPS $-0.22 N/A

Green = Better metric | Red = Weaker metric

View Full RVRC Analysis →
View Full RVPH Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

RVRC vs AAPL RVPH vs MSFT RVRC vs GOOGL RVPH vs AMZN

RVRC vs RVPH: Frequently Asked Questions

Is RVRC or RVPH a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), RVPH has stronger fundamentals. RVRC is rated STRONG SELL (88% confidence) while RVPH is rated STRONG SELL (90% confidence). This is not investment advice.

How does RVRC compare to RVPH fundamentally?

Revium Rx. has ROE of -195.5% vs REVIVA PHARMACEUTICALS HOLDINGS, INC.'s -229.7%. Net margins are N/A vs -16,167.8% respectively.

Which stock pays higher dividends, RVRC or RVPH?

RVRC has a dividend yield of N/A or no dividend while RVPH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in RVRC or RVPH for long term?

For long-term investing, consider that RVRC has STRONG SELL rating with 88% confidence, while RVPH has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about RVRC vs RVPH?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVRC vs RVPH, the AI consensus favors RVPH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.